TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
TCRR
Delisted
TCRR was delisted on the 31st of May, 2023.
117 hedge funds and large institutions have $270M invested in TCR2 Therapeutics Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 41 increasing their positions, 35 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding in top 10
Funds holding in top 10: →
53% less capital invested
Capital invested by funds: $572M → $270M (-$301M)
69% less call options, than puts
Call options by funds: $1.3M | Put options by funds: $4.14M
Holders
117
Holding in Top 10
2
Calls
$1.3M
Puts
$4.14M
Top Buyers
| 1 | +$4.94M | |
| 2 | +$4.63M | |
| 3 | +$4.06M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$3.16M |
| 5 |
Millennium Management
New York
|
+$2.32M |
Top Sellers
| 1 | -$22M | |
| 2 | -$15.3M | |
| 3 | -$6.1M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$4.86M |
| 5 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
-$2.91M |